Abstract：
BACKGROUND: Intrathecal baclofen, delivered via implanted pump, has been used to manage spasticity for approximately 40 years. The device is typically subcutaneously or subfascially implanted in the abdominal wall. There are very few cases reported of the pump being implanted in other locations.
METHODS: This case describes the complicated course of a patient presenting with multiple episodes of catheter malfunction related to pump flipping in the abdominal pocket. The patient was successfully treated with repositioning of the pump into the infraclavicular fossa.
CONCLUSIONS: Infraclavicular placement of the implanted pump allowed for a more secure pocket base for this patient and less strain applied to the pump, minimizing the risk of disruption of pump positioning and interruption of drug delivery.
METHODS: This case describes the complicated course of a patient presenting with multiple episodes of catheter malfunction related to pump flipping in the abdominal pocket. The patient was successfully treated with repositioning of the pump into the infraclavicular fossa.
CONCLUSIONS: Infraclavicular placement of the implanted pump allowed for a more secure pocket base for this patient and less strain applied to the pump, minimizing the risk of disruption of pump positioning and interruption of drug delivery.
摘要：
背景：鞘内注射巴氯芬，通过植入泵输送，已经被用来控制痉挛大约40年了。该装置通常皮下或筋膜下植入腹壁中。很少有报道将泵植入其他位置的病例。
方法：本病例描述了一名患者出现多次与腹袋泵翻转相关的导管故障的复杂过程。通过将泵重新定位到锁骨下窝中，成功治疗了患者。
结论：植入泵的锁骨下放置可以为患者提供更安全的口袋底座，并减少泵的应变。将泵定位中断和药物输送中断的风险降至最低。
方法：本病例描述了一名患者出现多次与腹袋泵翻转相关的导管故障的复杂过程。通过将泵重新定位到锁骨下窝中，成功治疗了患者。
结论：植入泵的锁骨下放置可以为患者提供更安全的口袋底座，并减少泵的应变。将泵定位中断和药物输送中断的风险降至最低。
